Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.2 (
NQO1
)
6,196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Japanese mugwort,
Artemisia princeps
(
yomogi
in Japanese), has anti-inflammatory and antioxidant effects. Skin care products containing
Artemisia princeps
extract (APE) are known to improve
dry skin
symptoms in atopic dermatitis. Atopic
dry skin
is associated with a marked reduction of skin barrier proteins, such as filaggrin (FLG) and loricrin (LOR). Recently, aryl hydrocarbon receptor (AHR), and its downstream transcription factor OVO-like 1 (OVOL1), have been shown to regulate the gene expression of FLG and LOR. The focus of this paper is to evaluate the effects of APE on the AHR/OVOL1/FLG or LOR pathway since they have remained unknown to this point. We first demonstrated that non-cytotoxic concentrations of APE significantly upregulated antioxidant enzymes,
NAD(P)H dehydrogenase
quinone 1 and heme oxygenase 1, in human keratinocytes. Even at these low concentrations, APE induced nuclear translocation of AHR and significantly upregulated
CYP1A1
(a specific target gene for AHR activation),
FLG
, and
LOR
expression. AHR knockdown downregulated
OVOL1
expression. The APE-induced upregulation of
FLG
and
LOR
was canceled in keratinocytes with AHR or OVOL1 knockdown. In conclusion, antioxidant APE is a potent phytoextract that upregulates
FLG
and
LOR
expression in an AHR/OVOL1-dependent manner and this may underpin the barrier-repairing effects of APE in treating atopic
dry skin
.
...
PMID:Antioxidant Artemisia princeps Extract Enhances the Expression of Filaggrin and Loricrin via the AHR/OVOL1 Pathway. 2889 18